| Literature DB >> 34024276 |
Claudia Prieto1,2, René M Botnar1,2, Giorgia Milotta3, Camila Munoz1, Karl P Kunze1,4, Radhouene Neji1,4, Stefano Figliozzi1, Amedeo Chiribiri1, Reza Hajhosseiny1, Pier Giorgio Masci1.
Abstract
PURPOSE: To develop a free-breathing whole-heart isotropic-resolution 3D late gadolinium enhancement (LGE) sequence with Dixon-encoding, which provides co-registered 3D grey-blood phase-sensitive inversion-recovery (PSIR) and complementary 3D fat volumes in a single scan of < 7 min.Entities:
Keywords: 3D whole-heart; Dixon water/fat separation; Late gadolinium enhancement; Respiratory motion correction
Mesh:
Substances:
Year: 2021 PMID: 34024276 PMCID: PMC8142497 DOI: 10.1186/s12968-021-00751-2
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Fig. 1Framework of the proposed 3D grey-blood phase sensitive inversion recovery (PSIR) late gadolinium enhancement (LGE) sequence. Two interleaved gradient echo (GRE) volumes with two-point Dixon encoding and 3 × undersampled spiral-like variable density Cartesian trajectory (VD-CASPR) are acquired with IR-preparation and no preparation respectively. Image navigators (iNAVs) are acquired prior to the 3D acquisition to correct for translational respiratory motion. The four echoes are motion corrected to end-expiration and reconstructed with iterative-SENSE. A water/fat separation algorithm is then used to obtain water and fat images for each acquired volume. An intermediate PSIR reconstruction between the in-phase echoes of each acquired volume is performed to estimate the signal polarity which is subsequently applied to the inversion recovery (IR)-prepared water volume to generate a water grey-blood PSIR image. The complementary fat-volume is obtained after water/fat separation of the reference volume
Gadolinium concentration, T1 values and inversion time (TI) used to null the signal in the IR-prepared image for each phantom vial
| Gd [mMol] | T1 [ms] | TI [ms] |
|---|---|---|
| 0.0 (H20) | 2883 | – |
| 0.1 | 1259 | 630 |
| 0.3 | 587 | 395 |
| 0.5 | 384 | 240 |
| 0.7 | 279 | 145 |
| 0.9 | 217 | 130 |
| 1 | 198 | 130 |
TI optimization was not performed to null the vial with 0.0 mMol of gadolinium concentration
Fig. 2a Gadolinium concentrations and disposition of the phantom vials. Concentrations of 0.3, 0.5 and 0.7 mMol corresponded respectively to the post-contrast T1 of healthy myocardium, blood and scar. b 3D IR magnitude images and PSIR reconstruction obtained by nulling with different inversion times each phantom vial (excluding the one with 0 mMol concentration). TI = 240 ms corresponds to blood nulling, TI = 395 ms corresponds to myocardium nulling. c Contrast ratio (CR) between myocardium, blood and scar obtained with blood and myocardium nulling. d Contrast to noise ratio (CNR) between myocardium, blood and scar obtained with blood and myocardium nulling
Fig. 3Co-registered 3D grey-blood PSIR LGE and fat volume obtained with the proposed approach and reformatted in different orientations (coronal, 2-chamber, 4-chamber and short-axis views) for one representative patient. Good depiction of scar is achieved in all the reformatted views. Good water/fat separation is obtained across the entire 3D volume. Contrast rations of CRblood-myoc = 1.11, CRscar-myoc = 1.32 and CRscar-blood = 1.19 were measured
Fig. 4Qualitative comparison between grey-blood PSIR LGE images obtained with the proposed 3D sequence and 2D clinical acquisition for four patients. The acquired 3D volumes were reformatted to the same slice position as the 2D images acquired in short-axis. Good scar depiction is observed with the proposed technique in comparison to the 2D acquisition for all the patients
Fig. 5a Contrast ratio (CR) and b contrast-to-noise ratio (CNR) between blood-myocardium, scar-myocardium and scar-blood obtained with the 2D (grey) and 3D (purple) approaches. Blood-myocardium CR and CNR were measured on 10 acquired patients, whereas the scar-myocardium and scar-blood CR and CNR were measured on the 6 patients with scar. No significant differences were observed between the CRs and CNRs obtained with 2D and 3D approaches
Average contrast ratio (CR) and contrast-to-noise (CNR) ratio measured between blood-myocardium, scar-myocardium and scar-blood for both 2D and 3D LGE PSIR images
| 2D | 3D | |||
|---|---|---|---|---|
| CR | CNR | CR | CNR | |
| Blood-myocardium | 1.29 ± 0.08 | 4.85 ± 2.01 | 1.28 ± 0.16 | 6.03 ± 2.78 |
| Scar-myocardium | 1.43 ± 0.15 | 7.02 ± 2.4 | 1.36 ± 0.12 | 8.45 ± 3.16 |
| Scar-blood | 1.15 ± 0.09 | 2.79 ± 1.29 | 1.14 ± 0.07 | 4.15 ± 2.48 |
Fig. 6Analysis performed by observer 1. a Expert image analysis for scar detection with the 17 segment American Heart Association (AHA) model. b Scar transmuarlity score performed on the patients showing a myocardial scar. Patient 5 was excluded from the analysis because contrast retainment was due to non-ischemic cardiomyopathy. c Comparison between 2 and 3D measurement of scar mass performed via Bland Altman analysis
Intra-observer variability Cohen's kappa scores of scar detection and overall image quality score. The intra-observer variability analysis was performed for both 2D and 3D grey-blood LGE datasets
| Intra-observer Variability | |||||
|---|---|---|---|---|---|
| 2D | 3D | ||||
| Patient no | Cohen kappa | Cohen kappa | |||
| Scar detection | 1 | 0.658 | 0.95 | 0.658 | 0.95 |
| 2 | 1 | – | 1 | – | |
| 3 | 1 | – | 1 | – | |
| 4 | 1 | – | 1 | – | |
| 5 | 1 | – | 1 | – | |
| 6 | 0.746 | 0.99 | 0.746 | 0.99 | |
| 7 | 0.883 | 0.99 | 0.883 | 0.99 | |
| 8 | 1 | – | 1 | – | |
| 9 | 1 | – | 1 | – | |
| 10 | 1 | – | 1 | – | |
| All patients | 0.898 | 0.99 | 0.898 | 0.99 | |
| Quality score | All patients | 1 | – | 1 | – |
Intra-observer variability for scar detection was computed for each patient considering each left ventricular (LV) segment in the analysis, and for all patients considering each segment of each patient in the analysis
Inter-observer variability assessment for scar detection, scar transmurality and overall quality score
| Inter-observer variability | |||||
|---|---|---|---|---|---|
| 2D | 3D | ||||
| Patient no | Cohen kappa | Cohen kappa | |||
| Scar detection | 1 | 0.811 | 0.99 | 0.811 | 0.99 |
| 2 | 1 | – | 1 | – | |
| 3 | 1 | – | 1 | – | |
| 4 | 1 | – | 1 | – | |
| 5 | 0.598 | 0.99 | 0.598 | 0.99 | |
| 6 | 0.638 | 0.99 | 0.638 | 0.99 | |
| 7 | 0.541 | 0.95 | 0.541 | 0.95 | |
| 8 | 0.638 | 0.95 | 0.638 | 0.95 | |
| 9 | 1 | – | 1 | – | |
| 10 | 1 | – | 1 | – | |
| All patients | 0.811 | 0.99 | 0.811 | 0.99 | |
| Scar transmurality | 1 | 0.667 | 0.99 | 0.667 | 0.99 |
| 4 | 0.622 | – | 0.805 | – | |
| 6 | 0.497 | 0.99 | 0.485 | 0.99 | |
| 7 | 0.512 | 0.99 | 0.439 | 0.99 | |
| All patients with scar | 0.589 | 0.99 | 0.544 | 0.99 | |
| Quality score | All patients | 0.615 | 0.95 | 0.5 | 0.95 |
The inter-observer variability analysis was performed for both 2D and 3D grey-blood late gadolinium enhancement (LGE) datasets. Inter-observer variability for scar detection was computed for each patient considering each LV segment in the analysis, ad for all patients considering each segment of each patient in the analysis. Inter-observer variability of scar transmurality was performed only for patients showing a myocardial scar